Implementation considerations of deprescribing interventions: a scoping review
Over half of older adults experience polypharmacy, including medications that may be
inappropriate or unnecessary. Deprescribing, which is the process of discontinuing or …
inappropriate or unnecessary. Deprescribing, which is the process of discontinuing or …
Risk assessment and prevention of falls in older community-dwelling adults: a review
CS Colón-Emeric, CL McDermott, DS Lee, SD Berry - JAMA, 2024 - jamanetwork.com
Importance Falls are reported by more than 14 million US adults aged 65 years or older
annually and can result in substantial morbidity, mortality, and health care expenditures …
annually and can result in substantial morbidity, mortality, and health care expenditures …
Revisiting systematic reviews on deprescribing trials to better inform future practice and research
A Spinewine, E Reeve… - British journal of clinical …, 2023 - Wiley Online Library
Deprescribing aims to address the problem of medication overuse in older adults. There has
been an increasing number of systematic reviews of 'deprescribing'. We aimed to describe …
been an increasing number of systematic reviews of 'deprescribing'. We aimed to describe …
How “age‐friendly” are deprescribing interventions? A scoping review of deprescribing trials
Objective To assess how age‐friendly deprescribing trials are regarding intervention design
and outcome assessment. Reduced use of potentially inappropriate medications (PIMs) can …
and outcome assessment. Reduced use of potentially inappropriate medications (PIMs) can …
Cost of adverse drug events related to potentially inappropriate medication use: a systematic review
Background The use of potentially inappropriate medications (PIMs) for older people is
associated with worse health outcomes owing to the occurrence of adverse drug events …
associated with worse health outcomes owing to the occurrence of adverse drug events …
Systematic review and meta-analysis on the effectiveness of multidisciplinary interventions to address polypharmacy in community-dwelling older adults
V Roncal-Belzunce, M Gutiérrez-Valencia… - Ageing research …, 2024 - Elsevier
Interventions to address polypharmacy in community-dwelling older adults often focus on
medication-related outcomes. The aim was to explore the impact of multidisciplinary …
medication-related outcomes. The aim was to explore the impact of multidisciplinary …
[HTML][HTML] Cost-effectiveness of a medication review intervention for general practitioners and their multimorbid older patients with polypharmacy
KT Jungo, P Salari, R Meier, M Bagattini… - Socio-Economic …, 2024 - Elsevier
Older adults with multiple chronic conditions and polypharmacy are at an increased risk of
having adverse health outcomes, affecting quality of life and generating costs. Primary care …
having adverse health outcomes, affecting quality of life and generating costs. Primary care …
[HTML][HTML] Value assessment of deprescribing interventions: suggestions for improvement
A Hung, J Wang, F Moriarty, V Manja… - Journal of the …, 2023 - ncbi.nlm.nih.gov
Corresponding Author: Anna Hung, PharmD, PhD, MS, Department of Population Health
Sciences, Duke University School of Medicine, Durham, NC 27701, 919-668-1493; anna …
Sciences, Duke University School of Medicine, Durham, NC 27701, 919-668-1493; anna …
Continuous glucose monitoring for the routine care of type 2 diabetes mellitus
RA Ajjan, T Battelino, X Cos, S Del Prato… - Nature Reviews …, 2024 - nature.com
Although continuous glucose monitoring (CGM) devices are now considered the standard of
care for people with type 1 diabetes mellitus, the uptake among people with type 2 diabetes …
care for people with type 1 diabetes mellitus, the uptake among people with type 2 diabetes …
Cost effectiveness of a GP delivered medication review to reduce polypharmacy and potentially inappropriate prescribing in older patients with multimorbidity in Irish …
P Gillespie, F Moriarty, SM Smith, A Hobbins… - The European Journal of …, 2024 - Springer
Background Evidence on the cost effectiveness of deprescribing in multimorbidity is limited.
Objective To investigate the cost effectiveness of a general practitioner (GP) delivered …
Objective To investigate the cost effectiveness of a general practitioner (GP) delivered …